SOLARA
Solara Active Pharma Sciences Ltd.
Each stock's 10,000-path forecast, rendered as light.
Solara Active Pharma Sciences Ltd. (SOLARA) Stock Analysis & Case Study
Is SOLARA a good buy? The data-driven verdict.
Solara Active Pharma Sciences Ltd. (SOLARA) trades at ₹511,on the numbers it high-risk on the numbers, a Downstox Snapshot Score of 25/100.
On the numbers, Solara Active Pharma Sciences Ltd. (SOLARA) high-risk on the numbers, a Downstox Snapshot Score of 25/100, weighing expensive at 572.0× earnings, ROE of -0.1%, a 50% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
SOLARA fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How SOLARA ranks against the 2,371 companies in our screener
- SOLARA's market cap of 2,444 Cr ranks in the 54th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- SOLARA's book value of ₹346 ranks in the 84th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- SOLARA's promoter holding of 41.9% ranks in the 19th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- SOLARA's 3-year profit (PAT) growth of 25.0% ranks in the 63rd percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- SOLARA's 3-year revenue growth of -2.0% ranks in the 20th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- SOLARA's debt-to-equity ratio of 0.55x is lower than 32% of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
Is SOLARA overvalued? SOLARA P/E vs peers
SOLARA trades at 572.0× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
SOLARA share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 8.0y of SOLARA history (9%/yr drift, 46%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| SOLARA 2027 | ₹280 | ₹502 | ₹901 | -0% |
| SOLARA 2028 | ₹219 | ₹502 | ₹1,153 | -0% |
| SOLARA 2029 | ₹179 | ₹502 | ₹1,407 | -0% |
| SOLARA 2030 | ₹155 | ₹502 | ₹1,626 | -0% |
| SOLARA 2031 | ₹137 | ₹501 | ₹1,842 | -0% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability SOLARA goes up, or doubles?
The bull case for SOLARA
- Low price-to-book of 1.48×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,407.
The bear case & risks
- SOLARA's P/E of 572.0x is lower than 2% of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- SOLARA's Piotroski F-Score of 3/8 ranks in the 15th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026.
- High historical volatility (46%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹179.
SOLARA volatility & expected range, how bumpy is the ride?
Over the last 8.0 years SOLARA compounded at 9%/year with annualized volatility of 46%. That volatility implies a 1-year 80% range of ₹280-₹901, the honest backbone behind any single price target.
SOLARA price forecast, the full 60-month probability fan
SOLARA price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds SOLARA hits common targets within the simulated horizon?
Full multi-horizon detail on the SOLARA price target & forecast page.
SOLARA Piotroski F-Score: 3/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. SOLARA scores 3/8, weak on the financial-strength checks.
SOLARA MTF margin & leverage across 10 brokers
Margin Trading Facility lets you buy SOLARA with part of the capital. Lower margin % = higher leverage. Rates compared across 10 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.83% | 2.8× |
| ZerodhaCHEAPEST | 35.79% | 2.8× |
| Groww | 36.01% | 2.8× |
| Dhan | 40.00% | 2.5× |
| Kotak Neo | 40.00% | 2.5× |
| Paytm Money | 44.83% | 2.2× |
| Pocketful | 36.14% | 2.8× |
| Anand RathiCHEAPEST | 35.79% | 2.8× |
| Bajaj Broking | 45.00% | 2.2× |
| Share India | 35.96% | 2.8× |
Compare every broker on the SOLARA MTF page.
About Solara Active Pharma Sciences Ltd.: sector, index & market-cap context
Solara Active Pharma Sciences Ltd. (SOLARA) is a small-cap NSE-listed company, with a market capitalisation of ₹2,444 Cr. See more stocks on our screener.
How the SOLARA Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Solara Active Pharma Sciences Ltd.'s public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
SOLARA analysis, FAQs
Is Solara Active Pharma Sciences Ltd. (SOLARA) a good buy?
On the numbers, Solara Active Pharma Sciences Ltd. (SOLARA) high-risk on the numbers, a Downstox Snapshot Score of 25/100, weighing expensive at 572.0× earnings, ROE of -0.1%, a 50% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is SOLARA overvalued or undervalued?
SOLARA trades at 572.0× earnings, expensive versus the ~22× long-run Nifty average.
What is the SOLARA share price target for 2031?
SOLARA's probability-weighted 2031 median target is ₹501, with an 80% range of ₹137-₹1,842 (10,000-path Monte-Carlo).
What is the probability SOLARA doubles in 5 years?
The modelled probability of SOLARA reaching ₹1,005 (2×) within 5 years is 25%.
What is the bull case for SOLARA?
Low price-to-book of 1.48×, the market is paying little over the company's net assets.
What are the risks in SOLARA?
SOLARA's P/E of 572.0x is lower than 2% of the 2,371 NSE companies in our screener, as of 8 Aug 2026. SOLARA's Piotroski F-Score of 3/8 ranks in the 15th percentile of the 2,371 NSE companies in our screener, as of 8 Aug 2026. High historical volatility (46%/yr) means a wide, bumpy range of outcomes, size positions accordingly.